Medical Policy: 06.01.31 
Original Effective Date: September 2013 
Reviewed: April 2016 
Revised: April 2016 


Benefit Application:

Benefit determinations are based on the applicable contract language in effect at the time the services were rendered. Exclusions, limitations or exceptions may apply. Benefits may vary based on contract, and individual member benefits must be verified. Wellmark determines medical necessity only if the benefit exists and no contract exclusions are applicable. This medical policy may not apply to FEP. Benefits are determined by the Federal Employee Program.

This Medical Policy document describes the status of medical technology at the time the document was developed. Since that time, new technology may have emerged or new medical literature may have been published. This Medical Policy will be reviewed regularly and be updated as scientific and medical literature becomes available.


Description:

Measurements of body composition have been used to study how lean body mass and body fat change during health and disease and have provided a research tool to study the metabolic effects of aging, obesity, and various wasting conditions such as occurs with AIDS or post bariatric surgery. A variety of techniques has been researched, including most commonly, anthropomorphic measures, bioelectrical impedance, and dual x-ray absorptiometry (DXA). All of these techniques are based in part on assumptions regarding the distribution of different body compartments and their density, and all rely on formulas to convert the measured parameter into an estimate of body composition. Therefore, all techniques will introduce variation based on how the underlying assumptions and formulas apply to different populations of subjects (ie, different age groups, ethnicities, or underlying conditions). Techniques using anthropomorphics, bioelectrical impedance, underwater weighing, and DXA are briefly reviewed as followed.

 

Anthropomorphic Techniques

Anthropomorphic techniques for the estimation of body composition include measurements of skinfold thickness at various sites, bone dimensions, and limb circumference. These measurements are used in various equations to predict body density and body fat. Due to its ease of use, measurement of skinfold thickness is one of the most commonly used techniques. The technique is based on the assumption that the subcutaneous adipose layer reflects total body fat, but this association may vary with age and sex.

 

Underwater Weighing

Underwater weighing requires the use of a specially constructed tank in which the subject is seated on a suspended chair. The subject is then submerged in the water while exhaling. While valued as a research tool, weighing people underwater is obviously not suitable for routine clinical use. This technique is based on the assumption that the body can be divided into 2 compartments with constant densities: adipose tissue, with a density of 0.9 g/cm3, and lean body mass (ie, muscle and bone), with a density of 1.1 g/cm3. One limitation of the underlying assumption is the variability in density between muscle and bone; for example, bone has a higher density than muscle, and bone mineral density varies with age and other conditions. In addition, the density of body fat may vary, depending on the relative components of its constituents (eg, glycerides, sterols, glycolipids).

 

Whole Body Dual X-Ray Absorptiometry (DXA)

While the cited techniques assume 2 body compartments, DXA can estimate 3 body compartments consisting of fat mass, lean body mass, and bone mass. DXA systems use a source that generates x-rays at 2 energies. The differential attenuation of the 2 energies is used to estimate bone mineral content and the soft tissue composition. When 2 x-ray energies are used, only 2 tissue compartments can be measured; therefore, soft tissue measurements (i.e. fat and lean body mass) can only be measured in areas in which no bone is present. DXA also has the ability to determine body composition in defined regions (i.e. the arms, legs, and trunk). DXA measurements are based in part on the assumption that the hydration of fat-free mass remains constant at 73%. Hydration, however, can vary from 67% to 85% and can be variable in certain disease states. Other assumptions used to derive body composition estimates are considered proprietary by DXA manufacturers.  

 

The use of DXA in the evaluation of body composition is becoming more widespread. Its purported uses entail determining appropriate nutritional support during disease progression and monitoring response to therapeutic interventions  It can be easily used in clinical studies and in various health care delivery locations, as a more convenient replacement for underwater weighing. However, one disadvantage is in regards to follow up. Follow up of a patient requires the use of the same DXA scanner and caution is needed when comparing results from different scanners.

 

The evidence for DXA body composition studies in patients who have a clinical condition associated with abnormal body composition includes several cross-sectional studies comparing DXA to other techniques. Relevant outcomes are symptoms and change in disease status. The available studies are primarily conducted in research settings and often use DXA body composition studies as a reference standard; these studies do not permit conclusions about accuracy of DXA for measuring body composition. More importantly, no studies were identified in which DXA body composition measurements were actively used in patient management. The evidence is insufficient to determine the effects of the technology on health outcomes.

 

The evidence for DXA body composition studies in patients who have a clinical condition managed by monitoring changes in body composition over time includes several prospective studies monitoring patients over time. Relevant outcomes are symptoms and change in disease status. The studies used DXA as a tool to measure body composition and were not designed to assess accuracy of DXA. None of the studies used DXA findings to make patient management decisions or addressed how serial body composition assessment might improve health outcomes. The evidence is insufficient to determine the effects of technology on health outcomes.

 

While DXA scans have become a valued research tool, it is unclear how information regarding body composition could be used in the active medical management of the patient to alter treatment decisions or improve health outcomes. No studies have been identified in the literature in which DXA body composition measurements were actively used in patient management, and studies have not reported data demonstrating the impact of body composition assessment on health outcomes. Therefore, the technique is considered investigational. 

 

Bioelectrical Impedance Analysis (BIA)

Bioelectrical impedance is based on the relationship between the volume of the conductor (i.e. human body), the conductor’s length (i.e. height), the components of the conductor (i.e. fat and fat-free mass), and its impedance. Estimates of body composition are based on the assumption that the overall conductivity of the human body is closely related to lean tissue. The impedance value is then combined with anthropomorphic data to give body compartment measures. The technique involves attaching surface electrodes to various locations on the arm and foot. Alternatively, the patient can stand on pad electrodes.

 

Studies indicate that BIA results were not as accurate, no matter which formula was used to do the calculations. For the general adult population, the relatively simple and inexpensive method of working out the BMI can produce results which are equal to, or even better, than the results of bioelectrical impedance analysis.

 

Based on review of the medical literature, there is currently no established role for whole body bioimpedance analysis for weight reduction or other indications. No studies have been identified in the literature in which bioimpedance analysis measurements were actively used in patient management, and studies have not reported data demonstrating the impact of body composition assessment on health outcomes. Further studies are needed to assess the clinical value of this testing.

 

Practice Guideline and Position Statements

International Society for Clinical Densitometry (ISCD)

In 2013, The International Society for Clinical Densitometry (ISCD) issued a statement on use of DXA body composition. The statement included the following ISCD official positions regarding the use of DXA total body composition with regional analysis:

  • To assess fat distribution in patients with HIV who are using antiretroviral agents known to increase the risk of lipoatrophy. The statement noted that, although most patients who were taking medications known to be associated with lipoatrophy switched to other medications, some remain on these medications and DXA may be useful in this population to detect changes in peripheral fat before they become clinically evident.
  • To assess fat and lean mass changes in obese patients undergoing bariatric surgery when weight loss exceeds approximately 10%. The statement noted that the impact of DXA studies on clinical outcomes in these patients is uncertain.
  • To assess fat and lean mass in patients with risk factors associated with sarcopenia, ie, with muscle weakness or poor physical functioning.

 

U.S. Preventative Services Task Force Recommendations (USPSTF)

The U.S. Preventative Services Task Force (USPSTF) does not recommend DXA for body compositions analysis. In 2012, USPSTF recommended screening all adults for obesity with BMI. Its 2010 recommendation on obesity in children and adolescents recommends screening all children older than 6 years old using BMI.   

 

American College of Cardiology (ACC)/American Heart Association (AHA)/The Obesity Society (TOS)

In 2013, the ACC/AHA/TOS issued a guideline for the management of overweight and obesity in adults and the summary of recommendations for obesity state, “identifying patients who need to lose weight (BMI and waist circumference), measure height and weight and calculate BMI at annual visits or more frequently. Measure weight circumference at annual visits or more frequently in overweight and obese adults.”
(E-Expert Opinion)

 

This guideline mentions no role of whole body DEXA/DXA or bioimpedance analysis in the assessment and management of overweight and obese adults. 

 

National Institute for Health and Clinical Excellence (NICE)

In 2014, NICE issued a guideline on obesity: identification, assessment and management. The guideline included the following: “measures of overweight and obesity adult and children do not use bioimpedance as a substitute for BMI as a measure of general adiposity.”


Prior Approval:

 

Not applicable.


Policy:

Whole body dual x-ray absorptiometry (DXA) and whole body bioelectrical impedance analysis (BIA) for body composition studies/assessment is considered investigational for all indications.

 

Based on the peer reviewed medical literature there is insufficient evidence to support the use of whole body DXA and whole body bioelectrical impedance analysis (BIA) for the purpose of determining body composition. It is unclear how information regarding body composition could be used in the active medical management of the patient to alter treatment decisions or improve health outcomes.  Well-designed studies evaluating the diagnostic accuracy and clinical utility of this testing are lacking.  Therefore, these techniques are considered investigational.



Procedure Codes and Billing Guidelines:

  • To report provider services, use appropriate CPT* codes, Alpha Numeric (HCPCS level 2) codes, Revenue codes, and/or diagnosis codes.
  • 76499 Unlisted diagnostic radiographic procedure
  • 0358T Bioelectrical impedance analysis whole body composition assessment, with interpretation and report

Selected References:

  • Methods for Body Composition Analysis in Adults, The Open Obesity Journal, 2011, Volume 3, 62-69
  • Centers for Disease Control and Prevention: Healthy Weight: Assessing Your Weight: BMI: About BMI for Adults.
  • U.S. Preventative Services Task Force: Screening for and Management of Obesity in Adults.
  • U.S. Preventative Services Task Force: Screening for Obesity in Children and Adolescents. 
  • American Heart Society Body Composition Tests
  • International Society for Clinical Densitometry: 2013 ISCD Official Positions-Adult.
  • International Society for Clinical Densitometry: 2007 Pediatric Official Positions.
  • Agency for Healthcare Research and Quality: Screening and Intervention for Childhood Overweight: Evidence Synthesis. July 2005. Investigators: Evelyn P. Whitlock, M.D., MPH; Selvi B. Williams, M.D.; Rachel Gold, PhD, MPH; Paula Smith, R.N., BSN; Scott Shipman, M.D., MPH
  • Evaluation of Lunar Prodigy dual energy x-ray absorptiometry for assessing body composition in healthy persons and patients by comparison with the criterion 4-component model. American Journal of Clinical Nutrition 2006. Jane E. Williams, Jonathan CK Wells, Catherine M. Wilson, Dalia Haroun, Alan Lucas and Mary S. Fewtrell.   
  • American College of Radiology (ACR) and the Society of Skeletal Radiology (SSR) Practice Guideline for the Performance of Dual Energy X-Ray Absorptiometry (DXA). Revised 2008
  • Pediatrics Official Journal of the American Academy of Pediatrics: Prevention of Pediatric Overweight and Obesity Committee on Nutrition, 2003, 112;424
  • ACR External SiteSPR-SSR Practice Parameter for the Performance of Dual-Energy X-Ray Asbsorptiometry (DXA), Amended 2014.
  • UpToDate External SiteMeasurement of Body Composition in Children, Sarah M. Phillips, MS, RD, LD, Robert J. Shulman, M.D., Topic last updated July17, 2015.
  • UpToDate External SiteDetermining Body Composition in Adults, George A. Bray, M.D., Topic last updated April 17, 2015.
  • Jensen MD, Ryan DH, Apovian CM, et al.; American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Obesity Society. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014;129(25 Suppl 2):S102-S138
  • National Institute for Health and Clinical Excellence External Site(NICE), NICE Guidelines (CG 189), Obesity: Identification, Assessment and Management. Published November 2014.
  • Ritz P, Salle A, Audran M, et. al. Comparison of different methods to assess body composition of weight loss in obese and diabetic patients. Diabetes Res Clin Pract 2007 Sep:77(3):405-11. PMID 17306903
  • Alves FD, Souza GC, Biolo A, et. al. Comparison of two bioelectrical impedance devices and dual-energy x-ray absorptiometry to evaluate body composition in heart failure, J Hum Nutr Diet 2014 Dec: 27(6):632-8. PMID 24684316
  • Ziai S, Coriati A, Chabot K, et. al. Agreement of bioelectric impedance analysis and dual-energy x-ray absorptiometry for body composition evaluation in adults with cystic fibrosis. J Cyst Fibros 2014 Sep:13(5):585-8. PMID 24522087
  • Elkan AC, Engvall IL, Tengstrand B, et. al. Malnutrition in women with rheumatoid arthritis is not revealed by clinical anthropometrical measurements or nutritional evaluation tools. Eur J Clin Nutr 2008 Oct:62(10):1239-47. PMID 17637600
  • Jensky-Squires NE, Dieli-Conwright CM, Rossuello A, et. al. Validity and reliability of body composition analysers in children and adults. BR J Nutr 2008 Oct:100 (4):859-65. PMID 18346304
  • Liem ET, De Lucia Rolfe E, L’Abee C, et. al. Measuring abdominal adiposity in 6 to 7 year old children. Eur J Clin Nutr 2009 Jul:63(7):835-41. PMID 19127281
  • Bedogni G, Agosti F, De Col A, et. al. Comparison of dual energy x-ray absorptiometry, air displacement pleythysmography and bioelectrical impedance analysis for the assessment of body composition in morbidly obese women. Eur J Clin Nutr 2013 Nov:67(11):1129-32. PMID 24022260
  • Tompuri TT, Lakka TA, Hakulinen M, et. al. Assessment of body composition by dual energy x-ray absorptiometry, bioimpedance analysis and anthropometrics in children: the physical activity and nutrition in children study. Clin Physiol Funct Imaging 2015 Jan:35(1):21-33. PMID 24325400
  • Kullberg J, Brandberg J, Angelhed JE, et. al. Whole body adipose tissue analysis: comparison of MRI, CT and dual energy x-ray absorptiometry. BR J Radiol. Feb 2009;85(974): 123-130. PMID 19168691
  • Monteiro PA, Antunes Bde M, Silveira LS, et. al. Body composition variables as predictors of NAFLD by ultrasound in obese children and adolescents. BMC Pediatr 2014;14:25. PMID 24476029
  • Bazzocchi A, Ponti F, Cariani S, et. al. Visceral fat and body composition changes in a female population after RYGBP: A Two year follow up by DXA. Obes Surg. Sep 14 2014. PMID 25218013 

Policy History:

  • April 2016 - Annual Review, Policy Revised
  • July 2015 - Annual Review, Policy Revised
  • August 2014 - Annual Review, Policy Renewed
  • September 2013 - New policy

Wellmark medical policies address the complex issue of technology assessment of new and emerging treatments, devices, drugs, etc.   They are developed to assist in administering plan benefits and constitute neither offers of coverage nor medical advice. Wellmark medical policies contain only a partial, general description of plan or program benefits and do not constitute a contract. Wellmark does not provide health care services and, therefore, cannot guarantee any results or outcomes. Participating providers are independent contractors in private practice and are neither employees nor agents of Wellmark or its affiliates. Treating providers are solely responsible for medical advice and treatment of members. Our medical policies may be updated and therefore are subject to change without notice.

*Current Procedural Terminology © 2012 American Medical Association. All Rights Reserved.